Department of Surgical Arrhythmology and Cardiac Pacing, Cardiology Research Institute, Tomsk National Research Medical Centre, Russian Academy of Sciences, Kievskaya st., 111a, Tomsk, Russian Federation, 634012.
Nuclear Medicine Department, Cardiology Research Institute, Tomsk National Research Medical Centre, Russian Academy of Sciences, Kievskaya street, 111a, Tomsk, Russian Federation.
Int J Cardiovasc Imaging. 2021 Nov;37(11):3323-3333. doi: 10.1007/s10554-021-02308-x. Epub 2021 Jun 7.
The conventional criteria for a defibrillation lead (DL) implantation don't take into account presence of scar or deep ischemia in the myocardium. This may impair a proper functioning of the DL. We sought to optimize the DL implantation placement using rest myocardial perfusion scintigraphy (MPS), which allow detecting areas of myocardial hypoperfusion (MH). To study the influence of MH and scarring, detected by MPS, on the DL parameters in patients with coronary artery disease (CAD). 69 patients (male-65, age 64.8 ± 7.7 years) with CAD and indications for ICD implantation were enrolled. Two days before ICD implantation all patients underwent MPS at rest. Then patients were divided in 2 groups. In the 1st group DL was implanted considering MPS results: to the septal position, if the most significant MH were detected in the apical segments, and to the apical position, if MH were in the septal segments. In the 2nd group DL was implanted using the conventional approach without considering MPS results. Clinical 12 months follow-up was performed with ICD interrogation. Patients of both groups were comparable by clinical and scintigraphic parameters. In the same time, in the 1st group pacing threshold was lower (p < 0.0001) and ventricle signal amplitude was higher (p < 0.0001) comparing with the 2nd group at all control points. The presence of MH detected by MPS in the area of the DL placement worsens its parameters. The results of MPS in patients with CAD can be useful for optimization of DL placement.
传统的除颤导联 (DL) 植入标准并未考虑心肌瘢痕或深部缺血的存在。这可能会影响 DL 的正常功能。我们试图使用静息心肌灌注闪烁显像 (MPS) 来优化 DL 的植入位置,MPS 可以检测到心肌低灌注 (MH) 的区域。研究 MPS 检测到的 MH 和瘢痕对冠心病 (CAD) 患者 DL 参数的影响。
共纳入 69 例有 CAD 且有 ICD 植入适应证的男性患者(年龄 64.8 ± 7.7 岁)。在 ICD 植入前 2 天,所有患者均行静息 MPS。然后将患者分为 2 组。第 1 组根据 MPS 结果植入 DL:如果在心尖段检测到最显著的 MH,则植入间隔位置;如果 MH 在间隔段,则植入心尖位置。第 2 组则采用传统方法植入 DL,不考虑 MPS 结果。通过 ICD 询问进行 12 个月的临床随访。两组患者的临床和闪烁扫描参数具有可比性。与此同时,在所有的检测点,第 1 组的起搏阈值更低 (p < 0.0001),心室信号幅度更高 (p < 0.0001)。
MPS 检测到的 MH 存在于 DL 放置区域会使 DL 参数恶化。CAD 患者的 MPS 结果可用于优化 DL 放置。